252 related articles for article (PubMed ID: 30660784)
1. Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis.
Gopalakrishnan V; Yao J; Steagall WK; Avila NA; Taveira-DaSilva AM; Stylianou M; Chen MY; Moss J
Chest; 2019 May; 155(5):962-971. PubMed ID: 30660784
[TBL] [Abstract][Full Text] [Related]
2. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.
Yao J; Taveira-DaSilva AM; Jones AM; Julien-Williams P; Stylianou M; Moss J
Am J Respir Crit Care Med; 2014 Dec; 190(11):1273-82. PubMed ID: 25329516
[TBL] [Abstract][Full Text] [Related]
3. Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.
Kim C; Do KH; Cha J; Song JW; Lee SM; Lee KY
Eur Radiol; 2020 Feb; 30(2):735-743. PubMed ID: 31471750
[TBL] [Abstract][Full Text] [Related]
4. CT grading of lung disease in lymphangioleiomyomatosis.
Yao J; Taveira-DaSilva AM; Colby TV; Moss J
AJR Am J Roentgenol; 2012 Oct; 199(4):787-93. PubMed ID: 22997369
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Treatment response to Sirolimus in pulmonary lymphangioleiomyomatosis by longitudinal quantification of cystic changes using automated post-processing of chest CT-data.
Albtoush OM; Horger M
Rofo; 2020 Dec; 192(12):1202-1204. PubMed ID: 32408352
[No Abstract] [Full Text] [Related]
6. A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.
Argula RG; Kokosi M; Lo P; Kim HJ; Ravenel JG; Meyer C; Goldin J; Lee HS; Strange C; McCormack FX;
Ann Am Thorac Soc; 2016 Mar; 13(3):342-9. PubMed ID: 26799509
[TBL] [Abstract][Full Text] [Related]
7. Computer grading of lung disease severity in patients with lymphangioleiomyomatosis referred for transplantation.
Taveira-DaSilva AM; Gopalakrishnan V; Yao J; Chen MY; Julien-Williams P; Jones AM; Pacheco-Rodriguez G; Moss J
BMC Pulm Med; 2022 Sep; 22(1):362. PubMed ID: 36153516
[TBL] [Abstract][Full Text] [Related]
8. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.
Taveira-DaSilva AM; Hathaway O; Stylianou M; Moss J
Ann Intern Med; 2011 Jun; 154(12):797-805, W-292-3. PubMed ID: 21690594
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).
Baldi BG; Araujo MS; Freitas CS; da Silva Teles GB; Kairalla RA; Dias OM; Pereira DA; Pimenta SP; Carvalho CR
Lung; 2014 Dec; 192(6):967-74. PubMed ID: 25201087
[TBL] [Abstract][Full Text] [Related]
10. Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis.
Matthew BP; Hasani AM; Chen YC; Pirooznia M; Stylianou M; Rollison SF; Machado TR; Quade NM; Jones AM; Julien-Williams P; Taveira-DaSilva A; Chen MY; Moss J; Wen H
Chest; 2021 Jul; 160(1):199-208. PubMed ID: 33549601
[TBL] [Abstract][Full Text] [Related]
11. Cyst Ventilation Heterogeneity and Alveolar Airspace Dilation as Early Disease Markers in Lymphangioleiomyomatosis.
Walkup LL; Roach DJ; Hall CS; Gupta N; Thomen RP; Cleveland ZI; McCormack FX; Woods JC
Ann Am Thorac Soc; 2019 Aug; 16(8):1008-1016. PubMed ID: 31038987
[No Abstract] [Full Text] [Related]
12. Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in Lymphangioleiomyomatosis.
Schmithorst VJ; Altes TA; Young LR; Franz DN; Bissler JJ; McCormack FX; Dardzinski BJ; Brody AS
AJR Am J Roentgenol; 2009 Apr; 192(4):1037-44. PubMed ID: 19304711
[TBL] [Abstract][Full Text] [Related]
13. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis.
Ussavarungsi K; Hu X; Scott JP; Erasmus DB; Mallea JM; Alvarez F; Lee AS; Keller CA; Ryu JH; Burger CD
Respir Med; 2015 Oct; 109(10):1354-9. PubMed ID: 26321137
[TBL] [Abstract][Full Text] [Related]
14. Durability of Sirolimus for Lymphangioleiomyomatosis.
Martirossian A; Shah S; Carrete L; Valle J; Valentine V
Am J Med Sci; 2017 Dec; 354(6):603-607. PubMed ID: 29208258
[TBL] [Abstract][Full Text] [Related]
15. Rates of change in FEV
Taveira-DaSilva AM; Julien-Williams P; Jones AM; Stylianou M; Moss J
Eur Respir J; 2018 Apr; 51(4):. PubMed ID: 29519926
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis.
Taveira-DaSilva AM; Jones AM; Julien-Williams P; Stylianou M; Moss J
Chest; 2018 Jan; 153(1):124-132. PubMed ID: 28533049
[TBL] [Abstract][Full Text] [Related]
17. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis.
Kato M; Kanehiro Y; Yoshimi K; Kodama Y; Sekiya M; Sato T; Takahashi K; Seyama K;
Respir Investig; 2018 Nov; 56(6):480-488. PubMed ID: 30143460
[TBL] [Abstract][Full Text] [Related]
18. Clinical CT underestimation of the percentage volume occupied by cysts in patients with lymphangioleiomyomatosis.
Larsen TC; Hasani AM; Rollison SF; Machado TR; Jones AM; Julien-Williams P; Chen MY; Moss J; Wen H
Clin Imaging; 2020 Feb; 59(2):119-125. PubMed ID: 31816538
[TBL] [Abstract][Full Text] [Related]
19. Cystic lung disease lymphangioleiomyomatosis (LAM) in a male patient.
Prakash AK; Chatterjee S; Datta B; Jaiswal A
BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37076194
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.
Gupta N; Lee HS; Young LR; Strange C; Moss J; Singer LG; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Downey GP; Taveira-DaSilva AM; Krischer JP; Setchell K; Trapnell BC; Inoue Y; McCormack FX;
Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30846465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
